Gujarat Themis Biosyn Ltd Share Price

Pharmaceuticals

NSE: GUJTHEM Small Cap ISIN: INE942C01045

As on 13 June 2026 at 01:11 IST

₹389.10

+ 5.80

(1.51%)

Sell Buy

Over 1 Month

-0.57%

Over 6 Months

-1.63%

Over 1 Year

9.99%

Over 3 Years

None%

Gujarat Themis Biosyn Ltd Summary

Close ₹383.30

Open ₹384.90

High ₹387.10

Low ₹377

Volume 41,720

Net Turnover (in Cr) ₹1.59

52Wk High ₹479

52Wk Low ₹225.05

52Wk High / Low

225.05

479

Gujarat Themis Biosyn Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹4,176.64

EPS (TTM) 4.28

Book Value (BV) 26.41

Div. Yield 0.18 %

P/E (TTM) 89.25

Price/Book Value 14.46

Delivery % 40.99 %

Face Value 1

Key Ratios

PE Ratio 62.83

PB Ratio 12.35

EV to Sales 20.46

PEG Ratio -1.40

ROA 17.44

ROE 21.69

Debt-Equity 0.07

Net Profit Margin 32.34

Operating Profit Margin 47.26

Gujarat Themis Biosyn Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	152.47	174.19	154.97	118.90	93.83
Total Expenses	86.94	94.85	77.51	59.87	52.95
Profit Before Tax	65.54	79.33	77.46	59.03	40.88
Profit After Tax	48.77	59.16	57.97	43.62	30.18
Operating Profit After Depreciation	65.90	79.56	77.64	59.86	41.86

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	41.29	38.02	32.66	19.43	18.95
Total Non Current Assets	249.34	173.55	104.60	44.11	24.94
Total Current Assets	51.97	47.56	61.73	78.39	63.32
Total Assets	301.31	221.11	166.33	122.50	88.26
Total Shareholder's Fund	248.38	201.38	149.15	103.32	69.95

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	91.03	64.21	39.48	40.31	10.53
Net Cash Used In Investing Activities	-111.82	-55.21	-20.41	-29.83	-2.25
Net Cash Used In Financing Activities	26.01	-8.59	-13.27	-14	-5.16

No data available

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	44.23	43.37	42.35	35.87	37.74
Total Expenses	24.87	22.06	21.40	21.96	21.70
Profit Before Tax	14.33	16.88	18.77	12.11	16.09
Profit After Tax	10.89	12.46	14.26	9.06	12
Operating Profit after Depreciation	20.28	21.73	21.77	14.18	17.39

Gujarat Themis Biosyn Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 377.83

S2 372.37

S3 367.73

Pivot 382.47

R1 387.93

R2 392.57

R3 398.03

Moving Average

20 SMA 385.64

50 SMA 349.28

100 SMA 331.26

200 SMA 372.25

Gujarat Themis Biosyn Ltd Corporate Actions

Gujarat Themis Biosyn Ltd

₹0.67/Share

Announcement Date 04 Sep 2025

Record Date 05 Sep 2025

Div Yield 67%

AGM Date: 17 Sep 2021

AGM 17/09/2021 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Financial Results of the Company for the Quarter ended 30thJune, 2021. A copy of Unaudited Financial Results of the Company for the Quarter ended 30th June, 2021 together with Limited Review Report is enclosed herewith. 2. Confirmed the time, and date of the 40th Annual General Meeting which will be held on Friday, 17th September, 2021 at 12:00 Noon. 3. Closure of Register of Members and Share Transfer Books from 11thSeptember, 2021 to 17th September, 2021 for the purpose of 40th Annual General Meeting. In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015, the Company has published the notice in ''Western Times'' (English) edition dated August26, 2021& in ''Western Times'' (Gujarati) edition dated August26, 2021, which includes the following information; a) Intimation of 40th Annual General Meeting (AGM) of our Company to be held through video conferencing / other audio-visual means and confirmation of dispatch of Annual Report for the Financial Year 2020-21, along with Notice of the AGM b) Particulars of the facility of e-voting provided to Members of the Company, to enable them to cast their votes on the resolutions proposed to be passed at the AGM. (As Per BSE Announcement Dated 26.08.2021) This has reference to our submission of proceedings on 17th September, 2021 for 40th Annual General Meeting held on Friday, 17th September, 2021, wherein the Resolution No. 2 was inadvertently pasted twice instead of pasting Resolution 2 & 3. We have therefore rectified the error and submitting the revised gist of proceeding of 40th Annual General Meeting of the Company held on Friday 17th September, 2021 after pasting the resolution No. 3. Kindly take the above intimation on your record. (As Per BSE Announcement dated on 19.09.2021) Gujarat Themis Biosyn Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.09.2021) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose gist of proceedings of 40th Annual General Meeting of the Company held on Friday 17th September, 2021. Kindly take the above intimation on your record. (As Per BSE Announcement Dated 17.09.2021)

AGM Date: 07 Sep 2022

AGM 07/09/2022 The Board of Directors at its meeting held today, considered and approved the following matters: Confirmed the time, and date of the 41st Annual General Meeting which will be held on Wednesday, 7th September, 2022 at 12:00 Noon. Closure of Register of Members and Share Transfer Books from Wednesday ,31st August, 2022 to Wednesday ,7th September, 2022 for the purpose of 41st Annual General Meeting and payment of dividend for the financial year 2021-22, if approved at the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 27.07.2022) In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 and in compliance with Ministry of Corporate Affairs Circular No. 20/2020 dated 5thMay, 2020 and Circular No. 02/2021 dated 13th January, 2021 read with the General Circular No. 02/2022 dated May 05, 2022 of the Ministry of Corporate Affairs ('MCA'),the Company has published the public notice of the 41st Annual General Meeting, Book Closure Annual General Meeting and other related information in ''Western Times'' (English) edition dated August 13, 2022 & in ''Western Times'' (Gujarati) edition dated August 13, 2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers. (As Per BSE Announcement Dated on 13/08/2022) Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of the Annual Report of the Company for the financial year ended 31st March, 2022 along with the Notice convening the 41st Annual General Meeting (AGM) to be held on Wednesday, September 7, 2022 at 12:00 Noon through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). (As Per BSE Announcement Dated on 16.08.2022) This is in furtherance to our letter dated 16th August, 2022 wherein the Company had submitted its Annual Report along with the Notice of the 41st AGM to be held on Wednesday, 7th September, 2022 at 12:00 Noon (IST) via Video Conference / Other Audio Visual Means and other Statutory Reports for Financial Year 2021-22. This is to inform you that the explanatory statement under Regulation 36(5) of the SEBI, LODR, 2015 relating to reappointment of Statutory Auditors was inadvertently missed out in the Notice of the Annual General Meeting for the Financial Year 2021-22. Therefore, vide this Corrigendum, the following necessary Explanatory Statement has been included and shall form in the Notice of the Annual General Meeting and necessary change has been made in the Annual Report. (As Per BSE Announcement Dated on 26.08.2022) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose gist of proceedings of 41st Annual General Meeting of the Company held on Wednesday, 7th September, 2022. Kindly take the above intimation on your record. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, The shareholders at 41st Annual General meeting held today considered the followings: 1. Continuation of Dr. Dinesh S Patel as Non- Executive Director on attaining the age of Seventy Five years. 2. Adopted New set of Articles of Association as per Companies Act, 2013. Kindly take the above intimation on your record. (As per BSE Announcement Dated on 7/9/2022) Gujarat Themis Biosyn Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 09.09.2022) As per the requirement of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, given below are the details of the voting results of the 41st Annual General Meeting (AGM) of the Company, held on Wednesday, 7th September, 2022, which commenced at 12:00 noon and concluded at 12:50 p.m. through Video Conferencing (''VC'')/Other Audio Visual Means (''OAVM'') as per the prescribed format under the said regulation as per the prescribed format under the said regulation. Further, consolidated Scrutinizer's Report on remote e-voting and e-voting at the AGM also enclosed herewith. Kindly consider this as compliance under Regulation 44(3) of the SEBI (LODR) Regulations, 2015. Kindly take the above intimation on your record. (As Per BSE Announcement Dated 08.09.2022)

AGM Date: 09 Sep 2023

The Board of Directors at its meeting held today, considered and approved the following matters: Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting E-Voting and Polling at the 42nd Annual General Meeting. In terms of Regulation 34 read with Regulation 30 of the SEBI (LODR) Regulations, 2015, we request you to refer attached corrigendum to the Annual Report for the FY 2022-23 of the Company. The Company has taken necessary steps to publish the same in the newspaper to inform all the shareholders of the Company. (As Per BSE Announcement dated on 18.08.2023) Please find enclosed Scrutinizer''s Report for the resolutions passed by the members in the AGM held on 9th September, 2023 (As Per BSE Announcement Dated on 11/09/2023)

AGM Date: 23 Jul 2024

Please find our intimation on the captioned subject. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, enclosed herewith gist of proceedings of 43rd Annual General meeting held on 23rd July, 2024. (As Per BSE Announcement dated on 23.07.2024)

AGM Date: 12 Sep 2025

AGM 12/09/2025 Please refer to the attachment. (As Per BSE Announcement Dated on 19.08.2025) Proceeding of the 44th AGM of Company held on Friday 12th September, 2025. Please refer to the attachment. (As Per BSE Announcement Dated on:12.09.2025)

Gujarat Themis Biosyn Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Gujarat Themis Biosyn Ltd Top Mutal Funds Invested

Fund Name	AUM
Quant Manufacturing Fund	5.67%
Quant Value Fund	0.56%
Bandhan BSE Healthcare Index Fund	0.09%

Gujarat Themis Biosyn Ltd News

Gujarat Themis Biosyn to conduct board meeting

On 6 June 2026

04 Jun 2026, 09:59 am

Board of Gujarat Themis Biosyn recommends final dividend

Of Rs 0.67 per share

25 May 2026, 06:42 pm

Gujarat Themis Biosyn jumps on acquisition of Japan-based MicroBiopharm

Gujarat Themis Biosyn surged 6.11% to Rs 391.40 after the company announced the acquisition of Japan-based MicroBiopharm Japan Co. (MBJ) for about JPY 21.5 billion, or nearly Rs 1,300 crore.

25 May 2026, 01:23 pm

Gujarat Themis Biosyn to conduct board meeting

On 25 May 2026

20 May 2026, 05:26 pm

Gujarat Themis Biosyn to conduct board meeting

On 5 February 2026

31 Jan 2026, 09:40 am

Gujarat Themis Biosyn Ltd Stock Analysis

Annual revenue for Gujarat Themis Biosyn Ltd decreased by 12.47% to ₹152.47 crore in FY 2025 from ₹174.19 crore in FY 2024.
Annual Net Profit for Gujarat Themis Biosyn Ltd decreased by 17.56% to ₹48.77 crore in FY 2025 from ₹59.16 crore in FY 2024.
Promoter Shareholding in Gujarat Themis Biosyn Ltd remains unchanged by 0.00% in the most recent quarter, from 70.86% in December 2025 to 70.86% in March 2026.
Gujarat Themis Biosyn Ltd delivered a 1-year return of 9.99% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Gujarat Themis Biosyn Ltd share price moved up by 1.51% from its previous close of INR ₹383.30. The latest Gujarat Themis Biosyn Ltd share price is INR ₹389.10.
Gujarat Themis Biosyn Ltd share price today has been at a low of 381.05 and a high of 392.40. Over the past 52 weeks, the Gujarat Themis Biosyn Ltd share price has seen a low of 225.05 and a high of 479.